Tiemann Investment Advisors LLC Grows Stake in McKesson Co. (NYSE:MCK)

Tiemann Investment Advisors LLC lifted its stake in McKesson Co. (NYSE:MCK) by 3.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 645 shares of the company’s stock after buying an additional 20 shares during the period. Tiemann Investment Advisors LLC’s holdings in McKesson were worth $368,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Synergy Asset Management LLC acquired a new stake in McKesson in the fourth quarter valued at approximately $32,000. MidAtlantic Capital Management Inc. purchased a new position in shares of McKesson in the third quarter valued at $29,000. Crews Bank & Trust acquired a new stake in McKesson during the 4th quarter valued at $33,000. RPg Family Wealth Advisory LLC purchased a new stake in McKesson during the 3rd quarter worth $31,000. Finally, Creative Capital Management Investments LLC acquired a new position in McKesson in the 4th quarter worth $44,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Buying and Selling at McKesson

In related news, EVP Leann B. Smith sold 579 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the sale, the executive vice president now owns 864 shares of the company’s stock, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $600.66, for a total transaction of $5,382,514.26. Following the transaction, the chief executive officer now directly owns 69,625 shares in the company, valued at approximately $41,820,952.50. The trade was a 11.40 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 18,689 shares of company stock worth $11,187,351. 0.11% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on MCK shares. StockNews.com downgraded McKesson from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Mizuho began coverage on McKesson in a research note on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price objective for the company. Morgan Stanley lifted their price objective on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Wells Fargo & Company increased their target price on McKesson from $535.00 to $641.00 and gave the company an “equal weight” rating in a research note on Friday, December 13th. Finally, Bank of America dropped their price target on shares of McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Two investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $645.79.

McKesson Stock Up 0.5 %

Shares of NYSE:MCK opened at $644.92 on Monday. The firm has a 50-day simple moving average of $600.67 and a 200 day simple moving average of $567.55. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $653.92. The company has a market cap of $80.82 billion, a PE ratio of 29.53, a P/E/G ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. As a group, research analysts forecast that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date is Monday, March 3rd. McKesson’s payout ratio is 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.